News
Market and company headlines
HNGEAll
Loading
05:00Oct 161 Story
04:00Oct 151 Story
11:00Oct 121 Story
09:00Oct 71 Story
06:00Oct 61 Story
12:00Oct 51 Story
08:00Oct 21 Story
16:00Oct 11 Story
02:00Sep 301 Story
11:00Sep 291 Story
10:00Sep 231 Story
04:00Sep 221 Story
13:00Sep 211 Story
02:00Sep 191 Story
07:00Sep 181 Story
07:00Sep 151 Story
07:00Sep 121 Story
13:00-19:00Aug 122 Stories
Hinge Health (HNGE) Just Bought Its Way Into A New Market, So Now What?
On August 4, Hinge Health (NASDAQ:HNGE) delivered a quarter that beat its own guidance on nearly every line, then turned around and used the extra cash to buy its way into a brand new category. Revenue grew 53% year-over-year, margins expanded by roughly 1,000 basis points, and the company still found $105 million to acquire […]
Is Hinge Health Stock a Buy as Growth Accelerates and Risks Rise?
HNGE's rapid revenue growth, widening margins and higher 2026 outlook strengthen its case, but expansion raises execution risks.
12:00Aug 122 Stories
Hinge Health's Cylinder Deal Opens a $135B GI Care Growth Opportunity
HNGE's $105 million Cylinder deal opens a $135 billion GI care market, adding nearly 100 clients and about 2 million lives.
HNGE Rallies 64.6% in 3 Months as Growth and Margins Gain Momentum
Hinge Health 64.6% three-month rally is backed by surging revenues, wider margins and a raised 2026 outlook, but execution expectations are rising.
07:00-12:00Aug 122 Stories
Is the Options Market Predicting a Spike in Hinge Health Stock?
Investors need to pay close attention to HNGE stock based on the movements in the options market lately.
Omada Health: Q2 Shows More Evidence Of Growth Converting Into Earnings
Omada Health (OMDA) delivered strong Q2 results, with 43% revenue growth, margin expansion, and positive adj. EBITDA, reinforcing my buy rating.
